Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: A prospective randomized clinical trial
- 31 July 1994
- journal article
- clinical trial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 97 (1), 55-59
- https://doi.org/10.1016/0002-9343(94)90048-5
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Mechanisms of Response to Treatment in Autoimmune Thrombocytopenic PurpuraNew England Journal of Medicine, 1989
- High Dose Intravenous Methylprednisolone for Chronic Idiopathic Thrombocytopenic PurpuraActa Haematologica, 1989
- High-Dose MethylprednIsolone for Chronic Idiopathic Thrombocytopenic PurpuraActa Haematologica, 1988
- Splenic pathology in immune thrombocytopenia.Journal of Clinical Pathology, 1985
- INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1985
- Long‐Term Follow‐Up Study of 168 Patients with Immune Thrombocytopenia. Implications for TherapyScandinavian Journal of Haematology, 1984
- Pulse Methylprednisolone Therapy in Idiopathic Thrombocytopenic PurpuraeActa Haematologica, 1983
- Chronic Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1981
- Platelet Antibodies in Thrombocytopenic PatientsBritish Journal of Haematology, 1977
- Clinical Experiences with Cytotoxic Immunosuppressive Treatment of Idiopathic Thrombocytopenic PurpuraActa Haematologica, 1971